A partial pathway- and network-based transformation reveals the synergistic mechanism of JA and UA against cerebral ischemia-reperfusion injury

[1]  H. Jafarinaveh,et al.  Proinflammatory cytokines in the embolic model of cerebral ischemia in rat. , 2014, Iranian journal of allergy, asthma, and immunology.

[2]  J. Switzer,et al.  Anti-inflammatory IL-10 is upregulated in both hemispheres after experimental ischemic stroke: Hypertension blunts the response , 2013, Experimental & Translational Stroke Medicine.

[3]  P. Wong,et al.  Comprehensive Gene Expression Profiling Reveals Synergistic Functional Networks in Cerebral Vessels after Hypertension or Hypercholesterolemia , 2013, PloS one.

[4]  Dong Zhang,et al.  Effect of berberine on cell cycle arrest and cell survival during cerebral ischemia and reperfusion and correlations with p53/cyclin D1 and PI3K/Akt. , 2013, European journal of pharmacology.

[5]  P. Vespa.  Hormonal dysfunction in neurocritical patients , 2013, Current opinion in critical care.

[6]  Jing Zhao,et al.  Neuroprotection by Curcumin in Ischemic Brain Injury Involves the Akt/Nrf2 Pathway , 2013, PloS one.

[7]  F. Kreutz,et al.  Resveratrol prevents global cerebral ischemia-induced decrease in lipid content , 2013, Neurological research.

[8]  Yi Wang,et al.  PI3K/Akt-independent negative regulation of JNK signaling by MKP-7 after cerebral ischemia in rat hippocampus , 2013, BMC Neuroscience.

[9]  Teresa M. Przytycka,et al.  Chapter 5: Network Biology Approach to Complex Diseases , 2012, PLoS Comput. Biol..

[10]  Zhan-Jun Zhang,et al.  Synergistic Mechanism of Gene Expression and Pathways between Jasminoidin and Ursodeoxycholic Acid in Treating Focal Cerebral Ischemia–Reperfusion Injury , 2012, CNS neuroscience & therapeutics.

[11]  K. Arai,et al.  Delayed Inhibition of c-Jun N-Terminal Kinase Worsens Outcomes after Focal Cerebral Ischemia , 2012, The Journal of Neuroscience.

[12]  Qingguo Wang,et al.  Chinese Medicine Injection Qingkailing for Treatment of Acute Ischemia Stroke: A Systematic Review of Randomized Controlled Trials , 2012, Evidence-based complementary and alternative medicine : eCAM.

[13]  J. Kalbfleisch,et al.  TLR2 Ligand Induces Protection against Cerebral Ischemia/Reperfusion Injury via Activation of Phosphoinositide 3-Kinase/Akt Signaling , 2011, The Journal of Immunology.

[14]  A. Meysamie,et al.  Favorable functional outcomes in acute ischemic stroke patients with subclinical hypothyroidism , 2011, Neurology.

[15]  Bo Zhang,et al.  Network target for screening synergistic drug combinations with application to traditional Chinese medicine , 2011, BMC Systems Biology.

[16]  R. M. Adibhatla,et al.  Protection by D609 Through Cell-Cycle Regulation After Stroke , 2010, Molecular Neurobiology.

[17]  F. Sharp,et al.  Brief Focal Cerebral Ischemia That Simulates Transient Ischemic Attacks in Humans Regulates Gene Expression in Rat Peripheral Blood , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  Chen Chen,et al.  Cell cycle inhibition attenuates microglial proliferation and production of IL‐1β, MIP‐1α, and NO after focal cerebral ischemia in the rat , 2009, Glia.

[19]  Kortaro Tanaka,et al.  Ambivalent Aspects of Interleukin-6 in Cerebral Ischemia: Inflammatory versus Neurotrophic Aspects , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  O. Lindvall,et al.  Brain inflammation and adult neurogenesis: The dual role of microglia , 2009, Neuroscience.

[21]  G. Steinberg,et al.  Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke , 2008, Journal of neuroscience research.

[22]  T. Anthony,et al.  Coping with stress: eIF2 kinases and translational control. , 2006, Biochemical Society transactions.

[23]  W. Daniel,et al.  Enhanced platelet activation by prolactin in patients with ischemic stroke , 2004, Thrombosis and Haemostasis.

[24]  R. Sapolsky,et al.  Akt Contributes to Neuroprotection by Hypothermia against Cerebral Ischemia in Rats , 2005, The Journal of Neuroscience.

[25]  M. Ginsberg,et al.  Mitochondria Consume Energy and Compromise Cellular Membrane Potential by Reversing ATP Synthetase Activity during Focal Ischemia in Rats , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  M. Karjalainen‐Lindsberg,et al.  Nuclear Factor- (cid:1) B Contributes to Infarction After Permanent Focal Ischemia , 2004 .

[27]  S. Schwab,et al.  Neuroendocrine changes in patients with acute space occupying ischaemic stroke , 2003, Journal of neurology, neurosurgery, and psychiatry.

[28]  A. Brasier,et al.  Vascular inflammation and the renin-angiotensin system. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[29]  Rita Kumar,et al.  Molecular Pathways of Protein Synthesis Inhibition during Brain Reperfusion: Implications for Neuronal Survival or Death , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  G. Feuerstein,et al.  Recombinant adenoviral expression of dominant negative IkappaBalpha protects brain from cerebral ischemic injury. , 2002, Biochemical and biophysical research communications.

[31]  S. R. Datta,et al.  Transcription-dependent and -independent control of neuronal survival by the PI3K–Akt signaling pathway , 2001, Current Opinion in Neurobiology.

[32]  S. Kassis,et al.  Inhibition of p38 mitogen‐activated protein kinase provides neuroprotection in cerebral focal ischemia , 2001, Medicinal research reviews.

[33]  S. Kassis,et al.  SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. , 2001, The Journal of pharmacology and experimental therapeutics.

[34]  G. Liu,et al.  Nimodipine inhibits calcium-independent nitric oxide synthase activity in transient focal cerebral ischemia rats and cultured mouse astroglial cells. , 1999, Life sciences.

[35]  H. Ellis.  stroke , 1997, The Lancet.

[36]  W. Hacke,et al.  Plasma insulin-like growth factor I and IGF binding protein 3 levels in patients with acute cerebral ischemic injury. , 1997, Stroke.

[37]  M. Reivich,et al.  Cytosolic Free Calcium During Focal Cerebral Ischemia and the Effects of Nimodipine on Calcium and Histologic Damage , 1990, Stroke.